Víctor Puente

Levodopa-carbidopa intestinal gel in advanced Parkinson's: Final results of the GLORIA registry

Angelo Antonini, Werner Poewe, К. Ray Chaudhuri et al. · Parkinsonism & Related Disorders · 2017 · 210 citations · Full text

Medicine, Neurology, Pharmacotherapy +15

Non-motor symptoms burden, mood, and gait problems are the most significant factors contributing to a poor quality of life in non-demented Parkinson's disease patients: Results from the COPPADIS Study Cohort

Diego Santos‐García, T. de Deus Fonticoba, E. Suárez Castro et al. · Parkinsonism & Related Disorders · 2019 · 147 citations

Medicine, Geriatric Medicine, Neurology +12

Previous antiplatelet therapy is an independent predictor of 30?day mortality after spontaneous supratentorial intracerebral hemorrhage

Jaume Roquer, Ana Rodríguez-Campello, Meritxell Gomis et al. · Journal of Neurology · 2005 · 118 citations

Medicine, Neurology, Pharmacotherapy +13

Sleep Disorders in Parkinsonian and Nonparkinsonian LRRK2 Mutation Carriers

Claustre Pont‐Sunyer, Álex Iranzo, Carles Gaig et al. · PLoS ONE · 2015 · 90 citations · Full text

Medicine, Genetics, Neurology +17

Long-term response to continuous duodenal infusion of levodopa/carbidopa gel in patients with advanced Parkinson disease: The Barcelona registry

Maríateresa Buongiorno, Francesca Antonelli, Ana Cámara et al. · Parkinsonism & Related Disorders · 2015 · 89 citations

Medicine, Neurology, Pharmacotherapy +10